BioSpace News Archive

Aurora Cannabis Inc. (“Aurora” or the “Company”) (NYSE | TSX: ACB), the Canadian company defining the future of cannabis worldwide, today announced that it has scheduled a conference call to discuss the results for its first quarter ended September 30, 2019 on Thursday, November 14th, 2019 at 6:00 p.m. Eastern Time.

CannaCraft, Inc., a large-scale cannabis manufacturer, announced today the appointment of Jim Hourigan as Chief Executive Officer, effective immediately

Natural Alternatives International, Inc. (“NAI”) (Nasdaq: NAII), the company behind SR CarnoSyn®, a patented, sustained-release version of CarnoSyn® beta-alanine, is showcasing several new ingredient solutions for healthy aging at the Age Management Medicine Group (AMMG) Conference in Tucson, AZ on November 7-10, 2019 at JW Marriott Tucson Starr Pass Resort & Spa.

Ryvu Therapeutics (WSE: RVU), a clinical-stage biopharmaceutical company developing novel small molecule therapies that address emerging targets in oncology, today announced that two abstracts have been accepted for presentation at the 61st American Society of Hematology (ASH) Annual Meeting in Orlando, FL, taking place from December 7-10, 2019.

Novel technology offers physicians first and only real-time detection and monitoring of endovascular bleed complications

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that new data for its approved and investigational medicines across a range of blood diseases will be presented at the 61st American Society of Hematology (ASH) Annual Meeting from December 7–10 in Orlando, Florida.

United Health Products, Inc. is rescheduling its corporate update conference call conference to Thursday November 7, 2019 at 4:30 pm Eastern Time; the call was originally scheduled for 11 am Eastern Time on the same date.

STAAR Surgical Company announced that the Company will host an Investor and Analyst Day on Friday, November 8, 2019 in New York City at 8:30 a.m. EST.

Third-Quarter 2019 Net Sales of $335.5 Million Increased 3 Percent; Third-Quarter 2019 GAAP Net Income of $18.2 Million; Adjusted EBITDA of $130.4 Million

LabCorp®, a leading global life sciences company, announced that John Ratliff is departing the company to pursue another opportunity.